Shire acquires Foresight Biotherapeutics, rights to late-stage drug FST-100.Published in:Optometry Times, 2015, v. 7, n. 9, p. 23Publication type:Article
Discover what's new in topical drugs.Published in:Optometry Times, 2011, v. 3, n. 7, p. 20By:Shapiro, AronPublication type:Article